Description
No mRNA – Spectra vaccines DO NOT use mRNA technology. Comprehensive 9-Way Protection – Helps protect healthy dogs 6 weeks of age and older against canine distemper, infectious canine hepatitis (CAV1), CAV2, parainfluenza, parvovirus, and four strains of Leptospira. Includes Leptospira Coverage – Diluent contains antigens for Leptospira canicola , L. icterohaemorrhagiae , L. grippotyphosa , and L. pomona for broader bacterial protection. Advanced Parvovirus Protection – Contains the CPV2b strain, shown to be effective against CPV2c, even in puppies with maternal antibodies. Cross-Protection Against CAV1 – The CAV2 fraction has been shown to be effective against disease caused by CAV1 (infectious canine hepatitis). Economical Combination Vaccine – Attenuated, immunogenic strains propagated in cell line tissue cultures, with gentamicin and thimerosal added as preservatives. Spectra™ 9 is a comprehensive, economical combination vaccine designed to help protect healthy dogs 6 weeks of age and older against a wide range of serious canine diseases. It contains immunogenic, attenuated strains of Canine Distemper (CDV), Canine Adenovirus Type 2 (CAV2), Canine Parainfluenza (CPIV), and Canine Parvovirus (CPV) type 2b, propagated in cell line tissue cultures. The accompanying diluent includes Leptospira bacterial antigens to provide added protection against multiple Leptospira species. The CAV2 fraction has been shown to be effective against disease caused by CAV1 (infectious canine hepatitis), offering broader adenovirus coverage. In addition, the CPV2b strain has demonstrated effective protection against CPV2c, even in puppies with maternal antibodies to parvovirus. Spectra™ 9 is formulated to aid in the prevention of canine distemper, infectious canine hepatitis, CAV2, parainfluenza, parvovirus, and Leptospira canicola , L. icterohaemorrhagiae , L. grippotyphosa , and L. pomona . Gentamicin and thimerosal are included as preservatives. The duration of immunity has not been determined.